Regional Anaesthesia Disposables Market size was valued at USD 518.6 Million in 2021 and is poised to grow at a significant CAGR of 5.6% over 2022–2028. Anesthesia Disposables have recently gained widespread recognition for their efficiency and advantages in various clinical and surgical procedures. The primary surgical operations or surgeries for which anesthetic disposables are used are ophthalmic surgery, cardiothoracic surgery, urologic surgery, neurosurgery, orthopaedic surgery, and other general surgery. The demand for disposable anaesthetic products, rising surgical cases worldwide, and increased attention to anaesthesia management in various chronic conditions are all driving growth in the worldwide anaesthesia disposables market. The medical device manufacturers have made significant investments in R&D activities to meet the current and latent demand for anaesthesia disposables due to the growing emphasis on pre-and post-operative anaesthetic evaluation and the rising economic burden of surgery complications. An additional element driving the anaesthesia disposables market is the global increase in the geriatric population suffering from chronic diseases. According to a 2017 United Nations report, there would be twice as many people in their 60s and beyond who are considered geriatrics by the year 2050. It is anticipated that there will be 2.1 billion people, up from 962 million in 2017. Furthermore, it has been noted that the baby boomer demographic is becoming more susceptible to various respiratory conditions, such as sleep apnea, chronic obstructive pulmonary disease (COPD), and asthma. Consequently, it is anticipated that demand for anaesthetic disposables will increase during the forecast period. Due to increasing R&D activity by key marketers and usage at the end user level, the global and regional markets for anaesthesia disposables are anticipated to rise rapidly in the expected timeframe. The market has been driven in recent years by expanding surgical operations worldwide and increasing attention to anaesthetic management in various chronic conditions. Growing preclinical operations by pharmaceutical companies and CROs and developing research and development in the cancer sectors are primarily responsible for the regional expansion. Increasing epidural anaesthesia during childbirth is anticipated to spur demand for disposable epidural anaesthesia devices.
Recent Market Developments:
In January 2022, ICU Medical acquired the Smiths Medical from Smiths Group plc. The acquisition focuses on investment into integration and infrastructure developed to support the Hospira Infusion Systems which was acquired in 2017.
In October 2021, Medovate, a company engaged in developing and commercializing innovative medical technologies, announced its first agreement in Asia with Bluestone Corporation Pte Ltd, to distribute SAFIRA (SAFer Injection for Regional Anesthesia) in Singapore.
In December 2020, Smiths Medical, a leading medical device manufacturer, launched EchoGlo peripheral nerve block portfolio. This offers customers a complete solution for regional anesthesia from the pump to patient.